These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31957081)

  • 1. The antiphospholipid syndrome - often overlooked cause of vascular occlusions?
    Svenungsson E; Antovic A
    J Intern Med; 2020 Apr; 287(4):349-372. PubMed ID: 31957081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
    J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome.
    George D; Erkan D
    Prog Cardiovasc Dis; 2009; 52(2):115-25. PubMed ID: 19732604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?
    Siddique S; Risse J; Canaud G; Zuily S
    Curr Rheumatol Rep; 2017 Sep; 19(10):64. PubMed ID: 28871481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
    Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A
    Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies?
    Noureldine MH; Harifi G; Berjawi A; Haydar AA; Nader M; Elnawar R; Sweid A; Al Saleh J; Khamashta MA; Uthman I
    Lupus; 2016 Nov; 25(13):1397-1411. PubMed ID: 27225212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome.
    Bertolaccini ML; Roch B; Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Br J Rheumatol; 1998 Nov; 37(11):1229-32. PubMed ID: 9851275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and classification of the antiphospholipid syndrome.
    Gómez-Puerta JA; Cervera R
    J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiphospholipid syndrome: from pathophysiology to treatment.
    Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
    Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.